Noa Greenberg-Kushnir, MD

MD

I was a research fellow in the Rivella lab between the years 2012-2013. My main project at the time was part of the lab’s effort to assess the anti-malignant influence of the cranberry extract, the A-PACs. My work focused on evaluating the A-PACs cytotoxic effect on breast cancer cells. Following the great experience in the Rivella lab, I moved to Dr. Wiest’s lab in the Fox Chase Cancer Center (Philadelphia, PA) where I studied the clinical significance of the Ribosomal Protein L22 in pediatric Acute Lymphoblastic Leukemia, as well as assessed relevant therapeutic interventions. Currently, I am doing my residency in pediatric medicine at the Sheba - Tel Ha SHomer Hospital.